Αρχική World News Skull Implant Delivers Drugs with Precision, Offering Hope for Parkinson’s, Cancer, Dementia

Skull Implant Delivers Drugs with Precision, Offering Hope for Parkinson’s, Cancer, Dementia

Christine Proctor’s children are grown up, and she has two young grandchildren that she’d love to see grow up as well. But she has Parkinson’s disease, which has already begun to take its toll on her quality of life. Chris knew she had to take a leap of faith if she was going to have a chance to spend many more years with her family.In an effort to treat the incurable condition, she’s taking part in the trials for a new piece of technology that delivers medication directly to the part of the brain where it’s needed via an implant in the skull.“I suppose it’s the biggest risk I’ve ever taken in my life actually,” says Chris. “But it was my risk, and it was about me.”Photo: YouTube/Parkinson’s UK
Chris has a port installed in the side of her head, to which a probe tool is attached to allow the medication to enter her brain each time she has a treatment session. Although she’s not able to feel the drug entering her brain through tiny tubes, she says it can be a little noisy when the device is attached to her port.“It sounds as though she’s furiously sharpening a pencil inside my head,” says Chris.Photo: YouTube/Parkinson’s UKOutside of treatment, she makes light of her new “body part,” calling it a third eye when she’s around her grandchildren. She tells them it allows her to see what they’re doing behind her back.
Photo: YouTube/Parkinson’s UKWhile this method of treatment is still in early trial phases, it’s showing a lot of promise for helping people like Chris, who have Parkinson’s disease, brain cancer, Alzheimer’s, or other neurological diseases, particularly incurable ones and those that are difficult to treat.In Chris’s case, researchers pump GDNF, a chemical the body naturally produces to restore nerve damage, directly into the putamen in the mid-brain, where neuron death has gradually caused a lack of coordination in the rest of the body. By doing this, they hope to prompt the brain to regrow neurons which will stop the progression of Chris’s Parkinson’s.
Photo: YouTube/Parkinson’s UKMost Parkinson’s patients see their neurological testing scores drop by about one point per year, but many of the 41 participants in this trial, like Chris, actually saw their scores increase by several points, averaging four points higher over nine months. Certain parts of their neurons even seem to be regrowing.Not all the results are as positive as they seem, because the placebo used on the control group also caused an increase in neurological scores. But the team believes the regrowth of cells is a good sign that some healing is happening.Photo: YouTube/Parkinson’s UK
“The system developed for use here has been proven safe in practice over 80 weeks, which is a remarkable achievement,” says Professor Roger Morris, from King’s College London, who was not involved with the trial. “If intra-brain perfusion can be safely achieved for long-term drug delivery inside the brain, the range of medication that can be used to combat brain diseases – stroke and cancer as well as neurodegeneration – will be massively expanded.”Photo: YouTube/Parkinson’s UKCould this be the key to helping patients with Parkinson’s, Alzheimer’s, cancerous brain tumors, and other neurological issues get the cure they seek or prolong their lives at a high quality? Only time will tell. For now, let’s thank our lucky stars that there’s one more promising technology out there to get us closer to the answers.Learn more about the amazing technology that may help treat or cure people with currently incurable neurological diseases in the video below.Proper BCS greatergood_ctg_abovevideoSource

NEWSLETTER

Συμπληρώστε το email σας για να λαμβάνετε τις σημαντικότερες ειδήσεις από το ogkologos.com

Βρείτε μας

2,449ΥποστηρικτέςΚάντε Like
57ΑκόλουθοιΑκολουθήστε

Διαβαστε Επίσης

ΕΞΕΛΙΞΕΙΣ ΣΤΗ ΘΕΡΑΠΕΙΑ ΤΟΥ ΜΗ-ΜΙΚΡΟΚΥΤΤΑΡΙΚΟΥ ΚΑΡΚΙΝΟΥ ΤΟΥ ΠΝΕΥΜΟΝΑ (ΜΜΚΠ)

ΕΞΕΛΙΞΕΙΣ ΣΤΗ ΘΕΡΑΠΕΙΑ ΤΟΥ ΜΗ-ΜΙΚΡΟΚΥΤΤΑΡΙΚΟΥ ΚΑΡΚΙΝΟΥ ΤΟΥ ΠΝΕΥΜΟΝΑ (ΜΜΚΠ) Γράφει ο Δρ Παπαδούρης Σάββας, Παθόλογος-Ογκολόγος   Ο ΜΜΚΠ βρίσκεται αναλογικά στο 80% και πλέον του συνολικού...

Διατρέχουν όντως οι καρκινοπαθείς μεγαλύτερο κίνδυνο λόγω κοροναϊού;

Σε πρακτικό επίπεδο, τα δεδομένα των σχετικών μελετών υποδηλώνουν ότι η χημειοθεραπεία ή οι άλλες αντι-νεοπλασματικές θεραπείες δεν αυξάνουν σημαντικά τον κίνδυνο θνησιμότητας από...

FDA: Η ακτινοβολία των smartphones δεν προκαλεί καρκίνο

Σε μια νέα έκθεσή της, η Υπηρεσία Τροφίμων και Φαρμάκων (FDA) των ΗΠΑ αναφέρει ότι επανεξέτασε τις σχετικές επιστημονικές έρευνες που δημοσιεύθηκαν τα τελευταία...

Νέα ανακάλυψη, νέα ελπίδα για τον καρκίνο

Ένα νεοανακαλυφθέν τμήμα του ανοσοποιητικού μας συστήματος θα μπορούσε να αξιοποιηθεί για την αντιμετώπιση όλων των ειδών καρκίνου, σύμφωνα με επιστήμονες του πανεπιστημίου Cardiff...

Καρκίνος: Ευεργετική για τους καρκινοπαθείς η άσκηση

Σημαντικά ωφέλη προσφέρει η άσκηση, ακόμη και σε ασθενείς με καρκίνο. Οι περισσότεροι ασθενείς αγνοούν τα οφέλη που μπορεί να έχει γι’ αυτούς η συχνή...

Prostate Cancer

The article is provided by Scientific Communications Officer of NIPD Genetics, Ms Marina Charitou (MSc) Prostate Cancer Awareness Prostate cancer is the second most common cancer...
- Advertisment -

Ροή Ειδήσεων

ESMO 2020: New Treatments for Advanced Kidney Cancer, Prostate Cancer, and Bladder Cancer

The 2020 European Society for Medical Oncology (ESMO) Virtual Congress was held online from September 19 to September 21. In this podcast, Neeraj Agarwal,...

The UK Government’s spending review: Time to invest in the future of cancer care

This autumn, the chancellor Rishi Sunak will go to Parliament and set out the UK Government’s spending priorities in the Comprehensive Spending Review...

FDA Extends Approval of Pembrolizumab for Classical Hodgkin Lymphoma

On 14 October 2020, the US Food and Drug Administration (FDA) extended the approval of pembrolizumab (KEYTRUDA®, Merck Sharp & Dohme Corp.) for the...

31-Year-Old Mother Dies of Cancer After Her Chemotherapy Was Paused During the Pandemic

The COVID-19 pandemic has been a scary and difficult thing for most of the world, and it’s important to keep safety protocols in place...

For Esophageal Cancer, Immunotherapy Likely to Play Larger Role

October 19, 2020, by NCI Staff An esophagram using barium contrast shows the esophagus. Credit: iStock Immunotherapy may become part of early treatment for some people with...

Targeted Therapy Based on Molecular Profiling of Malignant Mesothelioma Tumours Is Feasible

Targeted therapy recommendations can be made based on the molecular profiles of tumour samples from patients with metastatic malignant mesothelioma (MM) according to findings...